Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Molecular Profile | RET V804M RET Y806C |
| Therapy | Selpercatinib |
| Indication/Tumor Type | Advanced Solid Tumor |
| Response Type | decreased response |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| RET V804M RET Y806C | Advanced Solid Tumor | decreased response | Selpercatinib | Preclinical - Biochemical | Actionable | In a preclinical study, transformed human cells expressing RET V804M and Y806C in cis were less sensitive to Retevmo (selpercatinib) in culture (PMID: 35304457). | 35304457 |
| PubMed Id | Reference Title | Details |
|---|---|---|
| (35304457) | The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers. | Full reference... |